Related Experiment Video
Updated: Aug 19, 2026

Patch Clamp Recordings on Intact Dorsal Root Ganglia from Adult Rats
Published on: September 29, 2016
DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84
Wen-Shuang Gao1, Yu-Juan Qu1, Juan Huai1
1Rehabilitation Center, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Abstract:
Adaptor molecule downstream of kinase-3 (DOK3) is a vital regulator of innate immune responses in macrophages and B cells, and G-protein-coupled receptor 84 (GPR84) is significant in mediating the biosynthesis and maintenance of inflammatory mediators that are induced by neuropathic pain in microglia. In the present study, we determined the role of DOK3 in activating microglia-induced neuropathic pain and investigated the underlying mechanisms associated with GPR84. We found that knockdown of DOK3 in microglial cells dramatically reduced the levels of inflammatory factors, and we uncovered a physical association between DOK3 and GPR84 in the induction of inflammatory responses. We also observed that neuropathic pain and inflammatory responses induced by chronic constriction injury (CCI) of the sciatic nerve or intrathecal injection of a GPR84 agonist were compromised in DOK3-/- mice in vivo. Finally, enforced expression of DOK3 provoked inflammatory responses, and administration of pregabalin relieved neuropathic pain via inhibition of DOK3 expression. In conclusion, DOK3 induced neuropathic pain in mice by interacting with GPR84 in microglia. We hypothesize that targeting the adaptor protein DOK3 may open new avenues for pharmaceutical approaches to the alleviation of neuropathic pain in the spinal cord.
Insights
Adaptor protein DOK3 (downstream of kinase-3) activates microglia, driving neuropathic pain through interaction with GPR84. Targeting DOK3 offers a potential therapeutic strategy for spinal cord pain relief.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Adaptor molecule downstream of kinase-3 (DOK3) regulates innate immunity.
- G-protein-coupled receptor 84 (GPR84) mediates inflammatory mediators in neuropathic pain.
- Microglia play a key role in neuroinflammation and pain signaling.
Purpose of the Study:
- To determine the role of DOK3 in microglia-mediated neuropathic pain.
- To investigate the underlying mechanisms involving GPR84.
- To explore DOK3 as a potential therapeutic target for neuropathic pain.
Main Methods:
- Knockdown of DOK3 in microglial cells.
- Assessment of inflammatory factor levels.
- In vivo studies using DOK3 knockout mice and chronic constriction injury (CCI) model.
- Evaluation of GPR84 agonist effects.
- Analysis of pregabalin's impact on DOK3 expression.
Main Results:
- DOK3 knockdown significantly reduced inflammatory factors in microglia.
- A physical association between DOK3 and GPR84 was identified.
- Neuropathic pain and inflammation were reduced in DOK3 knockout mice.
- Pregabalin administration alleviated pain by inhibiting DOK3 expression.
Conclusions:
- DOK3 induces neuropathic pain via interaction with GPR84 in microglia.
- Targeting DOK3 presents a promising pharmaceutical approach for neuropathic pain management.
- This research highlights DOK3 as a key player in spinal cord pain mechanisms.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Analgesia and Pain Management

